scispace - formally typeset
A

Ario de Marco

Researcher at European Bioinformatics Institute

Publications -  46
Citations -  3069

Ario de Marco is an academic researcher from European Bioinformatics Institute. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 24, co-authored 34 publications receiving 2691 citations. Previous affiliations of Ario de Marco include University of Nova Gorica & European Institute of Oncology.

Papers
More filters
Journal ArticleDOI

Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

TL;DR: This article reviews the available strategies for exploiting the physiological mechanisms of bactera to produce properly folded disulfide-bonded proteins and recommends several strategies aimed at the formation and at the quality control of disulfides in the oxidizing periplasm.
Journal ArticleDOI

Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli.

TL;DR: The engineered E. coli strains and the two-step procedure presented here led to a remarkable increase in the solubility of a various recombinant proteins and should be applicable to a wide range of target proteins produced in biotechnology.
Journal ArticleDOI

NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies

TL;DR: This work describes the first fully synthetic phage display library of humanized llama single domain antibody (NaLi-H1: Nanobody Library Humanized 1), based on a humanized synthetic singledomain antibody (hs2dAb) scaffold optimized for intracellular stability, which provides high affinity binders without animal immunization.
Journal ArticleDOI

Native folding of aggregation-prone recombinant proteins in Escherichia coli by osmolytes, plasmid- or benzyl alcohol–overexpressed molecular chaperones

TL;DR: Combined strategies of osmolyte-induced native folding with heat-, BA-, or plasmid-induced chaperone coexpression can be thought to optimize yields of natively folded recombinant proteins in bacteria, for research and biotechnological purposes.